Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 8 pseudogene 11 (KRT8P11) is classified as a processed pseudogene related to the functional keratin 8 gene, which encodes a type II intermediate filament protein critical for structural support in epithelial cells[1][2][6]. Pseudogenes like KRT8P11 result from reverse transcription and integration events and are typically "nonfunctional": they do not encode proteins and generally lack regulatory elements required for transcription and translation[1][2][6]. There are dozens of keratin 8 pseudogenes scattered throughout the human genome, none of which are believed to retain an intact reading frame or biological activity[1][2][6]. Thus, KRT8P11 is not a therapeutic target, enzyme, transporter, or receptor, and currently has no known biological, pathological, or pharmacological relevance as a target in medicine. Key context: - Keratin 8 (KRT8), the functional parent gene, is an important intermediate filament protein; however, its pseudogenes, including KRT8P11, are considered genetic relics without direct biological function[1][2][6]. - There is no evidence that KRT8P11 or any keratin 8 pseudogene plays a role in disease, serves as a biomarker, or interacts with drugs[1][2][6]. - The name "keratin 8 pseudogene 11" follows a systematic nomenclature for pseudogenes; the "P" suffix and numbering system comes from consensus nomenclature efforts for the keratin gene family[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 8 pseudogene 11 (KRT8P11).